Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122370484 | 12237048 | 4 | F | 2016 | 20160803 | 20160405 | 20160810 | PER | US-AMGEN-USASL2016039911 | AMGEN | 46.00 | YR | A | F | Y | 0.00000 | 20160810 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122370484 | 12237048 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 1062887 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 122370484 | 12237048 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 1064413 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 122370484 | 12237048 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK, EVERY WEEK AND A HALF TO EVERY TWO WEEKS | U | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122370484 | 12237048 | 1 | Psoriatic arthropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122370484 | 12237048 | Chronic obstructive pulmonary disease | |
| 122370484 | 12237048 | Condition aggravated | |
| 122370484 | 12237048 | Dyspnoea | |
| 122370484 | 12237048 | Hand deformity | |
| 122370484 | 12237048 | Injection site bruising | |
| 122370484 | 12237048 | Injection site erythema | |
| 122370484 | 12237048 | Injection site haemorrhage | |
| 122370484 | 12237048 | Injection site pain | |
| 122370484 | 12237048 | Injection site pruritus | |
| 122370484 | 12237048 | Injection site reaction | |
| 122370484 | 12237048 | Injection site swelling | |
| 122370484 | 12237048 | Intentional product misuse | |
| 122370484 | 12237048 | Malaise | |
| 122370484 | 12237048 | Menstruation irregular | |
| 122370484 | 12237048 | Oropharyngeal pain | |
| 122370484 | 12237048 | Psoriasis | |
| 122370484 | 12237048 | Tendon injury | |
| 122370484 | 12237048 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122370484 | 12237048 | 1 | 20160315 | 0 | ||
| 122370484 | 12237048 | 2 | 2016 | 0 | ||
| 122370484 | 12237048 | 3 | 2016 | 0 |